|
|
||||||||
-Adrenergic vasoreactivity of canine intrapulmonary
bronchial arteries in pacing-induced heart
failure
Department of Physiology, University of South Alabama, Mobile, Alabama 36688
We hypothesized
that pacing-induced congestive heart failure alters
-adrenergic constriction in intrapulmonary bronchial arteries.
Cumulative dose responses to norepinephrine (NE), phenylephrine (PE),
acetylcholine (ACh) and sodium nitroprusside (SNP) were determined in
pressurized vessel segments. ED50
values for NE and PE were higher for control (
5.34 ± 0.09 and
4.27 ± 0.08 M, respectively) vs. paced (
5.73 ± 0.10 and
5.06 ± 0.28 M, respectively) groups. Prazosin
increased the ED50 values for NE
and PE in both control and paced groups. Yohimbine decreased NE
ED50 in the control group only.
Endothelium removal or nitric oxide synthase (NOS) inhibition decreased
control but not paced NE ED50.
Maximum vasodilation and sensitivity (i.e.,
ED50 values) were
decreased for ACh but were similar for SNP in paced vs. control groups.
Secondary segments were more reactive than paired primary segments in
both groups, although pacing effects on
ED50 were unrelated to branching
order. In conclusion, adrenergic constriction of canine intrapulmonary bronchial arteries is predominantly mediated via
1-adrenoreceptors and is
enhanced after pacing. Endothelium-derived relaxing factor(s) normally
opposes
-adrenergic vasoconstriction but not after pacing in this vasculature.
adrenergic vasoconstriction; pulmonary hypertension; endothelium-derived relaxing factor
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |